Temazepam Or Ambien: Which Is Safer For Seniors?

what is better for elderly for sleep ambien of temazepam

Ambien (zolpidem) and Restoril (temazepam) are two popular prescription medications used to treat insomnia and other sleep-related conditions. While both drugs are effective in helping people fall asleep faster and stay asleep throughout the night, they work in very different ways and come with unique side effects and risks. This raises the question: which is better for the elderly, Ambien or temazepam?

Characteristics Values
Brand Name Ambien/ Zolpidem
Treatment Short-term insomnia
Dosage 5 mg, 6.25 mg, 10 mg, 12.5 mg
Administration Orally, on an empty stomach
Side Effects Headaches, dry mouth, sleepwalking, sleep-driving, impaired driving, stomach cramps, nausea, skin flushing
Addiction Yes
Brand Name Restoril/ Temazepam
Treatment Short-term insomnia, seizures, anxiety, muscle spasms
Dosage 7.5 mg, 15 mg
Administration 15-30 minutes before desired sleep time
Side Effects Headaches, fatigue, hangover effect
Addiction Yes

shunsleep

Ambien is a non-benzodiazepine, whereas Restoril (temazepam) is a benzodiazepine

Restoril (temazepam) and Ambien (zolpidem) are prescription medications used to treat insomnia and other sleep-related conditions. Both drugs are considered controlled substances due to their potential for abuse and come with some common side effects such as headaches, fatigue, and the possibility of a hangover effect. However, they also have unique interaction profiles and warnings.

Ambien is a non-benzodiazepine sedative-hypnotic. It is part of a separate class of GABA-receptor agonists called imidazopyridines. It is a positive modulator at the GABA-A receptor and has a higher affinity for the omega-1 subunit of the GABA-A receptor. This is thought to explain why Ambien has a somnolent effect but no effects related to muscle relaxation, anxiety, or seizure activity. Ambien works by changing the brain chemicals responsible for sleep and depressing the central nervous system. It is available as an oral immediate-release tablet in 5 mg and 10 mg, as well as extended-release tablets in 6.25 mg and 12.5 mg. It is intended for short-term use and should be taken on an empty stomach.

Restoril, on the other hand, is a benzodiazepine. It is a central nervous system (CNS) depressant that affects gamma-aminobutyric acid (GABA) levels in the body. GABA is a neurotransmitter designed to calm the brain and nervous system. When Restoril binds to the brain's GABA receptors, it enhances these effects, creating a sedative state. Restoril has anxiolytic effects, making it an effective anti-anxiety medication. It works within 15 to 30 minutes of taking it and has a half-life of nine hours for staying asleep. Restoril is typically used for short-term insomnia and should be taken for ten days or fewer.

Both drugs have been proven effective in treating insomnia and improving sleep quality. However, a 2008 study found that patients receiving Ambien reported slightly better quality of sleep than those receiving Restoril. Additionally, Ambien is shown to be more effective than Restoril in reducing the number of awakenings after sleep onset, making it potentially more suitable for certain patients with insomnia. Nevertheless, both drugs have been linked to unusual behaviours during sleep, such as sleepwalking, sleep-driving, or sleep-eating.

shunsleep

Ambien is more effective at reducing awakenings and improving sleep efficiency

While both Ambien (zolpidem) and Restoril (temazepam) are prescription medications used to treat insomnia, Ambien has been shown to be more effective in reducing awakenings and improving sleep efficiency.

Ambien is a non-benzodiazepine sedative-hypnotic that works by changing the brain chemicals responsible for sleep and depressing the central nervous system. It is typically prescribed for short-term insomnia, particularly when falling and staying asleep is difficult. The drug has been available as a prescription sleep aid since the 1990s and is quite popular, with up to 9 million Americans using it regularly, according to a 2016 report by the New York Daily News.

Restoril, on the other hand, is a benzodiazepine that affects gamma-aminobutyric acid (GABA) levels in the body. GABA is a neurotransmitter that calms the brain and nervous system. Restoril is indicated for the treatment of short-term insomnia, usually lasting a few days or weeks and is often related to stressors or changes in sleep schedules. It is also used to treat seizures, anxiety, and muscle spasms.

A study comparing the hypnotic effects of zolpidem and temazepam found that zolpidem significantly reduced awakenings and wake after sleep onset (WASO), while temazepam did not. Zolpidem also provided greater subjective hypnotic efficacy than temazepam, with improved performance on the Digit Symbol Substitution Test (DSST). This suggests that Ambien is more effective at reducing awakenings and improving overall sleep quality, making it a potentially better option for elderly individuals struggling with insomnia and sleep efficiency.

It is important to note that both drugs are considered controlled substances due to their potential for abuse and addiction. They share common side effects such as headaches, fatigue, and the possibility of a hangover effect. Therefore, the choice between Ambien and Restoril should be carefully evaluated by a healthcare provider based on individual patient needs and conditions.

shunsleep

Elderly patients are at a higher risk of falls when taking Ambien

Ambien (zolpidem) and Restoril (temazepam) are prescription medications used to treat insomnia. While both drugs are effective in helping people fall asleep faster and stay asleep throughout the night, they have different mechanisms of action and side effects.

Elderly patients taking Ambien may experience an increased risk of falls for several reasons. Firstly, Ambien is a non-benzodiazepine sedative-hypnotic that affects the GABA-A receptor, specifically the omega-1 subunit. This action is believed to cause a somnolent effect, which can increase the risk of falls by impairing balance and coordination. Clinical research has consistently found that benzodiazepines and non-benzodiazepine sedatives are associated with an increased risk of falls in older adults.

Additionally, Ambien may cause side effects such as dizziness, confusion, and sedation, which can further contribute to the risk of falling. These side effects can be particularly dangerous for elderly individuals who may already have balance and mobility issues. It is important for elderly patients taking Ambien to be aware of these potential side effects and to use caution when performing activities that require balance and coordination.

Moreover, the risk of falls may be heightened in elderly patients due to the potential for drug interactions with Ambien. For example, combining Ambien with other central nervous system (CNS) depressants, such as alcohol or certain medications, can lead to increased sedation and impaired motor function, further elevating the risk of falls.

It is important to note that while the risk of falls associated with Ambien use in elderly patients is a concern, this does not necessarily mean that elderly individuals should avoid taking Ambien altogether. Instead, careful assessment by healthcare professionals is crucial to weigh the benefits against the risks for each individual patient. In some cases, the benefits of improved sleep may outweigh the potential risks of falls, especially if appropriate precautions are taken.

shunsleep

Restoril is more likely to cause addiction and withdrawal symptoms

Restoril (temazepam) is a benzodiazepine, which affects the central nervous system (CNS). It is a sedative-hypnotic prescription drug that is often used to treat insomnia and other sleep-related conditions. While Restoril can be effective in treating insomnia, it carries a significant risk of misuse, addiction, and withdrawal symptoms.

Benzodiazepines like Restoril work by enhancing the effects of gamma-aminobutyric acid (GABA), a neurotransmitter that calms the brain and nervous system. While this can be helpful in reducing anxiety and promoting sleep, it also has the potential to lead to dependence and addiction. Restoril use can result in physical dependence, where the body requires the drug to function normally, and discontinuing its use can lead to severe withdrawal symptoms.

Abruptly stopping or drastically reducing Restoril use can cause dangerous withdrawal symptoms, including tremors, seizures, sweating, nausea, muscle pain, and anxiety. These symptoms can surface within 6-8 hours after the last dose and typically peak at day 2, persisting for several days. To avoid these severe withdrawal symptoms, it is recommended to gradually taper off the medication under medical supervision.

While Ambien (zolpidem) also has the potential for misuse and addiction, the evidence suggests that Restoril may be more likely to cause addiction and severe withdrawal symptoms. This is due to its classification as a benzodiazepine, which is known to carry a higher risk of dependence and withdrawal compared to non-benzodiazepines like Ambien. Additionally, Restoril has anxiolytic effects, making it more likely to be misused as self-medication for anxiety without medical consultation, which can lead to addiction.

In summary, while both Restoril and Ambien are effective in treating insomnia and carry some risk of addiction, Restoril's classification as a benzodiazepine and its anxiolytic effects make it more likely to cause addiction and severe withdrawal symptoms. Therefore, it is crucial to use Restoril as directed by a healthcare professional and not to discontinue its use abruptly to minimise the risk of withdrawal.

Late Night Eating: Sleep Hungry or Eat?

You may want to see also

shunsleep

Ambien is intended for short-term use, while Lunesta is considered safe for long-term use

Ambien (zolpidem) and Lunesta (eszopiclone) are prescription sleep aids used to treat insomnia. They are classified as sedative-hypnotic drugs, which decrease brain activity and calm the body, helping you fall asleep. While both drugs have similar effects, they have different formulations and durations of action.

Ambien is a non-benzodiazepine sedative-hypnotic, which means it has no muscle relaxation, anxiety, or seizure activity effects. It is typically prescribed for short-term use, with a recommended duration of one to two weeks. The drug works by changing the brain chemicals responsible for sleep and depressing the central nervous system. It is available in 5mg and 10mg immediate-release tablets and 6.25mg and 12.5mg extended-release tablets. The extended-release version can help individuals fall asleep and/or stay asleep.

On the other hand, Lunesta is considered safe for long-term use and is effective for both short-term and long-term treatment of insomnia. It has a longer half-life than Ambien, at around six hours compared to Ambien's 2.5 hours. This means that Lunesta stays in the body for a longer period, potentially helping individuals stay asleep longer. The typical dose of Lunesta is 1mg per day for both men and women, with the option to increase it slowly if needed.

It is important to note that both drugs carry the risk of dependency and withdrawal symptoms. Side effects of Ambien include headaches, dry mouth, and, in rare cases, sleepwalking or sleep-driving. Lunesta may cause similar side effects, with headache and unpleasant taste being more common than with Ambien.

When deciding between Ambien and Lunesta, it is crucial to consult a healthcare professional. The most effective medication depends on individual needs, overall health condition, and other factors such as cost and insurance coverage.

Frequently asked questions

Restoril (temazepam) and Ambien (zolpidem) are prescription medications used to treat insomnia. Restoril is a benzodiazepine, which affects the central nervous system. Ambien, on the other hand, is a non-benzodiazepine sedative-hypnotic.

Both Restoril and Ambien can cause side effects such as headaches, fatigue, and the possibility of a hangover effect. However, Ambien has additional side effects such as sleepwalking and sleep-driving, which can occur even after the drug has worn off. It is important to note that both drugs are susceptible to abuse and can lead to addiction.

While both drugs can be used for elderly patients, Ambien is recommended at a lower dose of 5 mg for the elderly. Studies have shown that Ambien can cause a small but significant decrease in performance in the elderly, while there was no objective evidence of rebound insomnia at recommended doses. However, there was subjective evidence of impaired sleep in the elderly at doses above 5 mg. Therefore, it is important to consult a healthcare provider to determine the most suitable medication and dosage for an individual's needs and conditions.

Written by
Reviewed by

Explore related products

Share this post
Print
Did this article help you?

Leave a comment